Author

George Olipoh

Observed name: Olipoh, George

Observed institution: Ghana Institute of Management and Public Administration

OpenAlex ID: A5034049759

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

2018 · Nicholas O Opoku, Didier K Bakajika, et al. · The Lancet · 304

Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection

2022 · Didier Bakajika, Eric M Kanza, et al. · PLoS neglected tropical diseases · 150

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

2023 · Klodeta Kura, Philip Milton, et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 30

Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia

2024 · Eric M. Kanza, Amos Nyathirombo, et al. · Parasites & Vectors · 5

Determining the Optimal Dose of Moxidectin for Onchocerciasis Via Pharmacokinetic-pharmacodynamic (pk-pd) Modelling of Data From Healthy Volunteers and Patients With Onchocerciasis

2017 · Kris M. Jamsen, Carl M. J. Kirkpatrick, et al. · American Journal of Tropical Medicine and Hygiene · 3

Works count: 9

Citation count: 493

H-index: 4

I10-index: 3